ArticleJournal for immunotherapy of cancer2025
Non-α-biased IL-2 enhances both intratumoral and subcutaneous CpG/α-OX40 therapy, unleashing systemic antitumor immunity in mice.
Kejie Huang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.